Table 1. Features of the Participants With Subjective Cognitive Decline Plus in the Amyloid Imaging to Prevent Alzheimer Disease Diagnostic and Patient Management Study and Disclosure Modalities in the Whole Group and Disaggregating by Amyloid Status.
| Features | Whole group, No. (%) (N = 105) | By amyloid status | ||
|---|---|---|---|---|
| Positive, No. (%) (n = 27) | Negative, No. (%) (n = 78) | P value | ||
| Age, median (IQR), y | 69 (64-74) | 70 (66-74) | 67 (64-74) | .11 |
| Gender | ||||
| Men | 59 (56) | 14 (52) | 45 (58) | .76 |
| Women | 46 (44) | 13 (48) | 33 (42) | |
| Education, median (IQR), y | 15 (12-17) | 15 (13-17) | 15 (12-17) | .87 |
| MMSE, median (IQR) | 29 (28-30) | 29 (28-30) | 29 (28-30) | .78 |
| Communication that SCD+ is a risk condition for the future development of cognitive impairment and dementia (yes vs no) | 99 (94) | 26 (96) | 73 (94) | .97 |
| Face-to-face disclosure | 67 (64) | 22 (81) | 45 (58) | .047 |
| Disclosure duration, median (IQR), min | 30 (25-60) | 52 (30-60) | 30 (20-35) | <.001 |
| Presence of study partner | 7 (7) | 3 (11) | 4 (5) | .53 |
Abbreviations: MMSE, Mini Mental State Examination; SCD+, subjective cognitive decline plus.